U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443124) titled 'Simeox 200 US Study' on Feb. 19.
Brief Summary: The purpose of this single arm post-market observational study is to evaluate the short-term effectiveness of the Simeox 200 airway clearance device in improving airway clearance in adult patients aged 18 to 85 with bronchiectasis and chronic mucus hypersecretion. The study aims to establish a baseline for wet sputum weight production using the Simeox 200 device. Additionally, the study aims to assess the short-term effects of Simeox 200 on various outcomes, including lung function, respiratory symptoms, and health-related quality of life.
The study participants will undergo the follo...